Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Transcriptome profiling of adipose tissue reveals depot-specific metabolic alterations among colorectal cancer patients.

Haffa M, Lin T, Holowatyj AN, Kratz M, Toth R, Benner A, Gigic B, Habermann N, Schrotz-King P, Böhm J, Brenner H, Schneider M, Ulrich A, Herpel E, Schirmacher P, Straub BK, Nattenmüller J, Kauczor HU, Ball CR, Ulrich CM, Glimm H, Scherer D.

J Clin Endocrinol Metab. 2019 Jun 21. pii: jc.2019-00461. doi: 10.1210/jc.2019-00461. [Epub ahead of print]

PMID:
31225875
2.

CT-Quantified Adipose Tissue Distribution: Risk or Protective Factor for Complications after Rectal Cancer Surgery?

Nattenmüller J, Böhm J, Bagdassarjan A, Kulu Y, Gigic B, Schneider M, Kauczor HU, Ulrich CM, Ulrich A.

Obes Facts. 2019 May 3;12(3):259-271. doi: 10.1159/000499320. [Epub ahead of print]

3.

Inflammation- and angiogenesis-related biomarkers are correlated with cancer-related fatigue in colorectal cancer patients: Results from the ColoCare Study.

Himbert C, Ose J, Lin T, Warby CA, Gigic B, Steindorf K, Schrotz-King P, Abbenhardt-Martin C, Zielske L, Boehm J, Ulrich CM.

Eur J Cancer Care (Engl). 2019 Apr 24:e13055. doi: 10.1111/ecc.13055. [Epub ahead of print]

PMID:
31016796
4.

Plasma metabolites associated with colorectal cancer: A discovery-replication strategy.

Geijsen AJMR, Brezina S, Keski-Rahkonen P, Baierl A, Bachleitner-Hofmann T, Bergmann MM, Boehm J, Brenner H, Chang-Claude J, van Duijnhoven FJB, Gigic B, Gumpenberger T, Hofer P, Hoffmeister M, Holowatyj AN, Karner-Hanusch J, Kok DE, Leeb G, Ulvik A, Robinot N, Ose J, Stift A, Schrotz-King P, Ulrich AB, Ueland PM, Kampman E, Scalbert A, Habermann N, Gsur A, Ulrich CM.

Int J Cancer. 2019 Jan 21. doi: 10.1002/ijc.32146. [Epub ahead of print]

PMID:
30665271
5.

The ColoCare Study: A Paradigm of Transdisciplinary Science in Colorectal Cancer Outcomes.

Ulrich CM, Gigic B, Böhm J, Ose J, Viskochil R, Schneider M, Colditz GA, Figueiredo JC, Grady WM, Li CI, Shibata D, Siegel EM, Toriola AT, Ulrich A.

Cancer Epidemiol Biomarkers Prev. 2019 Mar;28(3):591-601. doi: 10.1158/1055-9965.EPI-18-0773. Epub 2018 Dec 6.

PMID:
30523039
6.

Body Fatness, Adipose Tissue Compartments, and Biomarkers of Inflammation and Angiogenesis in Colorectal Cancer: The ColoCare Study.

Himbert C, Ose J, Nattenmüller J, Warby CA, Holowatyj AN, Böhm J, Lin T, Haffa M, Gigic B, Hardikar S, Scherer D, Zielske L, Schrotz-King P, Kölsch T, Siegel EM, Shibata D, Ulrich A, Schneider M, Hursting SD, Kauczor HU, Ulrich CM.

Cancer Epidemiol Biomarkers Prev. 2019 Jan;28(1):76-82. doi: 10.1158/1055-9965.EPI-18-0654. Epub 2018 Oct 17.

PMID:
30333223
7.

Associations of branched-chain amino acids with parameters of energy balance and survival in colorectal cancer patients: Results from the ColoCare Study.

Delphan M, Lin T, Liesenfeld DB, Nattenmüller J, Böhm JT, Gigic B, Habermann N, Zielske L, Schrotz-King P, Schneider M, Ulrich A, Kauczor HU, Ulrich CM, Ose J.

Metabolomics. 2018 Mar;2018(14):22. doi: 10.1007/s11306-017-1314-8. Epub 2018 Jan 31.

8.

Robust prediction of gene regulation in colorectal cancer tissues from DNA methylation profiles.

Klett H, Balavarca Y, Toth R, Gigic B, Habermann N, Scherer D, Schrotz-King P, Ulrich A, Schirmacher P, Herpel E, Brenner H, Ulrich CM, Michels KB, Busch H, Boerries M.

Epigenetics. 2018;13(4):386-397. doi: 10.1080/15592294.2018.1460034. Epub 2018 May 3.

9.

Associations Between Dietary Patterns and Longitudinal Quality of Life Changes in Colorectal Cancer Patients: The ColoCare Study.

Gigic B, Boeing H, Toth R, Böhm J, Habermann N, Scherer D, Schrotz-King P, Abbenhardt-Martin C, Skender S, Brenner H, Chang-Claude J, Hoffmeister M, Syrjala K, Jacobsen PB, Schneider M, Ulrich A, Ulrich CM.

Nutr Cancer. 2018 Jan;70(1):51-60. doi: 10.1080/01635581.2018.1397707. Epub 2017 Dec 15.

10.

Smoking is associated with hypermethylation of the APC 1A promoter in colorectal cancer: the ColoCare Study.

Barrow TM, Klett H, Toth R, Böhm J, Gigic B, Habermann N, Scherer D, Schrotz-King P, Skender S, Abbenhardt-Martin C, Zielske L, Schneider M, Ulrich A, Schirmacher P, Herpel E, Brenner H, Busch H, Boerries M, Ulrich CM, Michels KB.

J Pathol. 2017 Nov;243(3):366-375. doi: 10.1002/path.4955. Epub 2017 Sep 29.

11.

Discovery of novel plasma proteins as biomarkers for the development of incisional hernias after midline incision in patients with colorectal cancer: The ColoCare study.

Böhm J, Pianka F, Stüttgen N, Rho J, Gigic B, Zhang Y, Habermann N, Schrotz-King P, Abbenhardt-Martin C, Zielske L, Lampe PD, Ulrich A, Diener MK, Ulrich CM.

Surgery. 2017 Mar;161(3):808-817. doi: 10.1016/j.surg.2016.08.025. Epub 2016 Oct 13.

12.

CT-based compartmental quantification of adipose tissue versus body metrics in colorectal cancer patients.

Nattenmueller J, Hoegenauer H, Boehm J, Scherer D, Paskow M, Gigic B, Schrotz-King P, Grenacher L, Ulrich C, Kauczor HU.

Eur Radiol. 2016 Nov;26(11):4131-4140. Epub 2016 Feb 6.

13.

Metabolomics and transcriptomics identify pathway differences between visceral and subcutaneous adipose tissue in colorectal cancer patients: the ColoCare study.

Liesenfeld DB, Grapov D, Fahrmann JF, Salou M, Scherer D, Toth R, Habermann N, Böhm J, Schrotz-King P, Gigic B, Schneider M, Ulrich A, Herpel E, Schirmacher P, Fiehn O, Lampe JW, Ulrich CM.

Am J Clin Nutr. 2015 Aug;102(2):433-43. doi: 10.3945/ajcn.114.103804. Epub 2015 Jul 8.

14.

Repeat physical activity measurement by accelerometry among colorectal cancer patients--feasibility and minimal number of days of monitoring.

Skender S, Schrotz-King P, Böhm J, Abbenhardt C, Gigic B, Chang-Claude J, Siegel EM, Steindorf K, Ulrich CM.

BMC Res Notes. 2015 Jun 6;8:222. doi: 10.1186/s13104-015-1168-y.

15.

Suitability of circulating miRNAs as potential prognostic markers in colorectal cancer.

Ristau J, Staffa J, Schrotz-King P, Gigic B, Makar KW, Hoffmeister M, Brenner H, Ulrich A, Schneider M, Ulrich CM, Habermann N.

Cancer Epidemiol Biomarkers Prev. 2014 Dec;23(12):2632-7. doi: 10.1158/1055-9965.EPI-14-0556.

16.

Impact of genetic polymorphisms on adenoma recurrence and toxicity in a COX2 inhibitor (celecoxib) trial: results from a pilot study.

Kraus S, Hummler S, Toriola AT, Poole EM, Scherer D, Kotzmann J, Makar KW, Kazanov D, Galazan L, Naumov I, Coghill AE, Duggan D, Gigic B, Arber N, Ulrich CM.

Pharmacogenet Genomics. 2013 Aug;23(8):428-437. doi: 10.1097/FPC.0b013e3283631784.

17.

Continuous monitoring of toxicity in clinical trials - simulating the risk of stopping prematurely.

Aamot H, Gigic B, Abel U, Karapanagiotou-Schenkel I.

Int J Clin Pharmacol Ther. 2010 Jul;48(7):476-7. No abstract available.

PMID:
20557850
18.

Socio-medicinal aspects of vibration-induced white finger disease.

Voelter-Mahlknecht S, Pritsch M, Gigic B, Langer P, Loeffler KI, Dupuis H, Letzel S.

Disabil Rehabil. 2008;30(14):999-1013. doi: 10.1080/09638280701443292.

PMID:
18584376

Supplemental Content

Support Center